Skip to content

Clinical trials

Active, not recruiting Neoplasm Metastasis trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Status: Active, not recruiting Country / region: Singapore Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20215
20226
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Novartis Pharmaceuticals3
ARCAGY/ GINECO GROUP1
Ascendis Pharma Oncology Division A/S1
Boehringer Ingelheim1
Celcuity Inc1
Changi General Hospital1
Mirati Therapeutics Inc.1
National University Hospital, Singapore1
Revolution Medicines, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis14
Carcinoma, Non-Small-Cell Lung4
Breast Neoplasms3
Colorectal Neoplasms3
Carcinoma2
Endometrial Neoplasms2
Lung Neoplasms2
Adrenal Gland Neoplasms1
Appendiceal Neoplasms1
Bronchial Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.